Acadia Pharmaceuticals Inc.

$ACAD is surging today after winning in its patent suit over Nuplazid, a drug used in the treatment of Parkinson’s disease

Share this article:

About the Author:

Acadia Pharmaceuticals Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup